IART Integra LifeSciences Holdings Corporation
Stable Earnings Power
F 30.0 / 100 pillar composite

AlphaQuality composite grade, weighted for stable earnings power businesses.

⚠ 2 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a stable earnings power business.

Grade overrides the 30.0 pillar composite — hard gates always win.

Profitability

Weight: 20%
F 11
  • 5yr Avg ROIC 1.1%
  • Operating Margin Trend -3.08 pp/yr

Capital Efficiency

Weight: 15%
D 36
  • 5yr Avg ROE -2.0%
  • 5yr Share-Count CAGR -2.7%

Growth Quality

Weight: 15%
D- 30
  • 5yr Revenue CAGR 1.5%
  • 5yr EPS CAGR -34.9%
  • Revenue-Growth Years (5) 4/5

Cash Generation

Weight: 15%
B 75
  • 5yr FCF Margin 7.1%
  • 5yr FCF/NI Conversion 1.28x

Balance Sheet

Weight: 20%
F 3
  • Net Debt / EBITDA 10.00x
  • Interest Coverage (EBIT/Int) -5.53x
  • Altman Z-Score 0.79

Stability

Weight: 15%
C- 50
  • EPS Volatility (σ/μ) 0.51
  • Piotroski F-Score 5
  • Negative-Revenue Years (5) 1/5

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Trimming

1 of 1 gurus held; 1 trimmed.

Holders
1
Avg Δ position
-17.1%
New buys
0
Full exits
0
As of Q1 2026